{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T01:23:19Z","timestamp":1791249799970,"version":"4.1.0"},"reference-count":148,"publisher":"Wiley","issue":"9","license":[{"start":{"date-parts":[[2022,7,26]],"date-time":"2022-07-26T00:00:00Z","timestamp":1658793600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/100000133","name":"Agency for Healthcare Research and Quality","doi-asserted-by":"publisher","award":["R01HS026215"],"award-info":[{"award-number":["R01HS026215"]}],"id":[{"id":"10.13039\/100000133","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["K08DA049905"],"award-info":[{"award-number":["K08DA049905"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["UG1DA015815"],"award-info":[{"award-number":["UG1DA015815"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["shmpublications.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Journal of Hospital Medicine"],"published-print":{"date-parts":[[2022,9]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Hospital\u2010based clinicians frequently care for patients with opioid withdrawal or opioid use disorder (OUD) and are well\u2010positioned to identify and initiate treatment for these patients. With rising numbers of hospitalizations related to opioid use and opioid\u2010related overdose, the Society of Hospital Medicine convened a working group to develop a Consensus Statement on the management of OUD and associated conditions among hospitalized adults. The guidance statement is intended for clinicians practicing medicine in the inpatient setting (e.g., hospitalists, primary care physicians, family physicians, advanced practice nurses, and physician assistants) and is intended to apply to hospitalized adults at risk for, or diagnosed with, OUD. To develop the Consensus Statement, the working group conducted a systematic review of relevant guidelines and composed a draft statement based on extracted recommendations. Next, the working group obtained feedback on the draft statement from external experts in addiction medicine, SHM members, professional societies, harm reduction organizations and advocacy groups, and peer reviewers. The iterative development process resulted in a final Consensus Statement consisting of 18 recommendations covering the following topics: (1) identification and treatment of OUD and opioid withdrawal, (2) perioperative and acute pain management in patients with OUD, and (3) methods to optimize care transitions at hospital discharge for patients with OUD. Most recommendations in the Consensus Statement were derived from guidelines based on observational studies and expert consensus. Due to the lack of rigorous evidence supporting key aspects of OUD\u2010related care, the working group identified important issues necessitating future research and exploration.<\/jats:p>","DOI":"10.1002\/jhm.12893","type":"journal-article","created":{"date-parts":[[2022,7,26]],"date-time":"2022-07-26T16:20:45Z","timestamp":1658852445000},"page":"744-756","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":55,"title":["Management of opioid use disorder and associated conditions among hospitalized adults: A Consensus Statement from the Society of Hospital Medicine"],"prefix":"10.1002","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0584-7783","authenticated-orcid":false,"given":"Susan L.","family":"Calcaterra","sequence":"first","affiliation":[{"name":"Department of Medicine, Division of General Internal Medicine, Division of Hospital Medicine University of Colorado Aurora Colorado USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8727-0289","authenticated-orcid":false,"given":"Marlene","family":"Martin","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Hospital Medicine, San Francisco General Hospital University of California San Francisco San Francisco California USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Bottner","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Dell Medical School The University of\u00a0Texas Austin Texas USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Honora","family":"Englander","sequence":"additional","affiliation":[{"name":"Department of Medicine Section of Addiction Medicine, Division of Hospital Medicine Oregon Health and Science University Portland Oregon USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoe","family":"Weinstein","sequence":"additional","affiliation":[{"name":"Section of General Internal Medicine Boston University School of Medicine Boston Massachusetts USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa B.","family":"Weimer","sequence":"additional","affiliation":[{"name":"Department of Medicine Yale School of Medicine New Haven Connecticut USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugene","family":"Lambert","sequence":"additional","affiliation":[{"name":"Department of Medicine Harvard Medical School, Division of General Internal Medicine, Massachusetts General Hospital Boston Massachusetts USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8005-4727","authenticated-orcid":false,"given":"Shoshana J.","family":"Herzig","sequence":"additional","affiliation":[{"name":"Department of Medicine Harvard Medical School, Division of General Internal Medicine, Massachusetts General Hospital Boston Massachusetts USA"},{"name":"Department of Medicine Beth Israel Deaconess Medical Center Boston Massachusetts USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2022,7,26]]},"reference":[{"key":"e_1_2_8_2_1","unstructured":"National Center for Health Statistics. Drug overdose deaths in the U.S. top 100 000 annually. Centers for Disease Control and Prevention. November 17 \u00a02021. Accessed May 22 2022.https:\/\/www.cdc.gov\/nchs\/pressroom\/nchs_press_releases\/2021\/20211117.htm"},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2019.20622"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.7326\/M17-3107"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.1111\/jrh.12307"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2018.20391"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2019.0876"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2020.107968"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2019.12562"},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2019.05.003"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2020.108207"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.1111\/add.15393"},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.16228"},{"key":"e_1_2_8_14_1","doi-asserted-by":"crossref","unstructured":"KingC CookR KorthuisPT MorrisCD EnglanderH.Causes of death in the 12\u200amonths after hospital discharge among patients with opioid use disorder.J Addict Med. Published online September 10 2021.doi:10.1097\/adm.0000000000000915","DOI":"10.1097\/ADM.0000000000000915"},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.hjdsi.2021.100579"},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.1097\/ADM.0000000000000487"},{"key":"e_1_2_8_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcna.2018.03.001"},{"key":"e_1_2_8_18_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-021-06849-8"},{"key":"e_1_2_8_19_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjoq-2020-001111"},{"key":"e_1_2_8_20_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.311.7001.376"},{"key":"e_1_2_8_21_1","unstructured":"Substance Abuse and Mental Health Services Administration. Key substance use and mental health indicators in the United States: Results from the National Survey on Drug Use and Health (HHS Publication No. PEP21\u201007\u201001\u2010003 NSDUH Series H\u201056). Rockville MD: Center for Behavioral Health Statistics and Quality Substance Abuse and Mental Health Services Administration.\u00a02020. Accessed June 8 2022.https:\/\/www.samhsa.gov\/data\/sites\/default\/files\/reports\/rpt35325\/NSDUHFFRPDFWHTMLFiles2020\/2020NSDUHFFR1PDFW102121.pdf"},{"key":"e_1_2_8_22_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11414-016-9538-3"},{"key":"e_1_2_8_23_1","doi-asserted-by":"publisher","DOI":"10.1080\/08897077.2014.930372"},{"key":"e_1_2_8_24_1","doi-asserted-by":"publisher","DOI":"10.1111\/add.14699"},{"issue":"1","key":"e_1_2_8_25_1","first-page":"51","article-title":"Human rights, stigma, and substance use","volume":"22","author":"Wogen J","year":"2020","journal-title":"Health Hum Rights"},{"key":"e_1_2_8_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2020.108209"},{"key":"e_1_2_8_27_1","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.2012.301191"},{"key":"e_1_2_8_28_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2014.2147"},{"key":"e_1_2_8_29_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-43133-8_33"},{"key":"e_1_2_8_30_1","unstructured":"National Institute on Drug Abuse. Screening and assessment tools chart. National Institute on Drug Abuse. March 21 \u00a02022. Accessed May 24 2022.https:\/\/www.drugabuse.gov\/nidamed-medical-health-professionals\/screening-tools-resources\/chart-screening-tools"},{"key":"e_1_2_8_31_1","doi-asserted-by":"publisher","DOI":"10.7326\/M16-0317"},{"key":"e_1_2_8_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2015.02.007"},{"key":"e_1_2_8_33_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12913-017-2354-5"},{"key":"e_1_2_8_34_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.books.9780890425596"},{"key":"e_1_2_8_35_1","doi-asserted-by":"publisher","DOI":"10.1002\/wps.20050"},{"key":"e_1_2_8_36_1","doi-asserted-by":"publisher","DOI":"10.1177\/1178633719883282"},{"key":"e_1_2_8_37_1","doi-asserted-by":"publisher","DOI":"10.1080\/10826084.2020.1858106"},{"key":"e_1_2_8_38_1","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.2019.305366"},{"key":"e_1_2_8_39_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1515195"},{"key":"e_1_2_8_40_1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.rr7004a1"},{"key":"e_1_2_8_41_1","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000002125"},{"key":"e_1_2_8_42_1","doi-asserted-by":"publisher","DOI":"10.7326\/M18-1203"},{"key":"e_1_2_8_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2019.05.010"},{"issue":"14","key":"e_1_2_8_44_1","first-page":"1","article-title":"Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health\u2010care settings","volume":"55","author":"Branson BM","year":"2006","journal-title":"MMWR Recomm Rep"},{"key":"e_1_2_8_45_1","unstructured":"Centers for Disease Control and\u00a0 Prevention. Screening Recommendations and Considerations Referenced in Treatment Guidelines and Original Sources.\u00a0September 15 \u00a02021. Accessed May 24 2022.https:\/\/www.cdc.gov\/std\/treatment-guidelines\/screening-recommendations.htm"},{"key":"e_1_2_8_46_1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.rr6902a1"},{"key":"e_1_2_8_47_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.22882"},{"key":"e_1_2_8_48_1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.rr6905a1"},{"key":"e_1_2_8_49_1","doi-asserted-by":"publisher","DOI":"10.1210\/er.2009-0009"},{"key":"e_1_2_8_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0376-8716(03)00062-0"},{"key":"e_1_2_8_51_1","doi-asserted-by":"publisher","DOI":"10.1300\/J069v18n04_05"},{"key":"e_1_2_8_52_1","unstructured":"Center for Substance Abuse Treatment. SAMHSA\/CSAT Treatment Improvement Protocols. Alcohol and Other Drug Screening of Hospitalized Trauma Patients. Substance Abuse and Mental Health Services Administration (US);\u00a01995.https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK82999\/"},{"key":"e_1_2_8_53_1","unstructured":"Center for Substance Abuse Treatment. A guide to substance abuse services for primary care clinicians. Appendix B. Legal and Ethical Issues. Treatment Improvement Protocol (TIP) Series Substance Abuse and Mental Health Services Administration;\u00a01997.http:\/\/integratedrecovery.org\/wp-content\/uploads\/2019\/12\/TIP24-SA.Services.for_.Primary.Care_.Clinicians.pdf"},{"key":"e_1_2_8_54_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(03)00236-5"},{"key":"e_1_2_8_55_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp1109283"},{"key":"e_1_2_8_56_1","volume-title":"Crossing the Quality Chasm: a New Health System for the 21st Century","author":"Institute of Medicine Committee on Quality of Health Care in America","year":"2001"},{"key":"e_1_2_8_57_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.j1550"},{"key":"e_1_2_8_58_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2017.3206"},{"key":"e_1_2_8_59_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)32812-X"},{"key":"e_1_2_8_60_1","unstructured":"Center for Substance Abuse Treatment. Medications for opioid use disorder. Treatment improvement protocol (TIP) series 63. Substance Abuse and Mental Health Services Administration. Vol. DHHS Publication No. (SMA) 05\u20104048;\u00a02005."},{"key":"e_1_2_8_61_1","doi-asserted-by":"publisher","DOI":"10.1080\/02791072.2003.10400007"},{"key":"e_1_2_8_62_1","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.2010.352"},{"key":"e_1_2_8_63_1","unstructured":"U.S. Department of Justice DEA Diversion Control Division. Title 21 Code of Federal Regulations 1306.07: Administering or dispensing of narcotic drugs. United States Drug Enforcement Administration.\u00a0November 2 \u00a02020. Accessed May 24 2022.https:\/\/www.ecfr.gov\/current\/title-21\/chapter-II\/part-1306\/subject-group-ECFR1eb5bb3a23fddd0\/section-1306.07"},{"issue":"2","key":"e_1_2_8_64_1","first-page":"1","article-title":"Managing opioid use disorder during and after acute hospitalization: a case\u2010based review clarifying methadone regulation for acute care settings","volume":"4","author":"Noska A","year":"2015","journal-title":"J Addict Behav Ther Rehabil"},{"key":"e_1_2_8_65_1","doi-asserted-by":"publisher","DOI":"10.1111\/add.12333"},{"key":"e_1_2_8_66_1","doi-asserted-by":"publisher","DOI":"10.1080\/10550887.2011.642758"},{"key":"e_1_2_8_67_1","unstructured":"Yale Department of Emergency Medicine. A guide for patients beginning buprenorphine treatment at home.\u00a0September 24 \u00a02019. \u00a0Accessed May 24 2022.https:\/\/medicine.yale.edu\/edbup\/quickstart\/Home_Buprenorphine_Initiation_338574_42801_v1.pdf"},{"key":"e_1_2_8_68_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-008-0866-8"},{"key":"e_1_2_8_69_1","unstructured":"GasperJ HarterK HerringA et al. Buprenorphine (Bup) Hospital Quick Start. Accessed May 24 2022.https:\/\/static1.squarespace.com\/static\/5c412ab755b02cec3b4ed998\/t\/5f5ff10736ebc23814307021\/1600123145998\/REFERENCES+-+Bup+Hospital+Quick+Start+-+September+2020.pdf"},{"key":"e_1_2_8_70_1","unstructured":"Substance Abuse and Mental Health Services Administration.Buprenorphine quick start guide. Accessed May 24 2022.https:\/\/www.samhsa.gov\/sites\/default\/files\/quick-start-guide.pdf"},{"key":"e_1_2_8_71_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.17128"},{"key":"e_1_2_8_72_1","doi-asserted-by":"publisher","DOI":"10.1097\/ADM.0000000000000864"},{"key":"e_1_2_8_73_1","doi-asserted-by":"publisher","DOI":"10.1097\/CXA.0000000000000072"},{"key":"e_1_2_8_74_1","doi-asserted-by":"publisher","DOI":"10.1111\/ajad.13135"},{"key":"e_1_2_8_75_1","doi-asserted-by":"publisher","DOI":"10.1111\/ajad.13069"},{"key":"e_1_2_8_76_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.ADM.0000435321.39251.d7"},{"key":"e_1_2_8_77_1","doi-asserted-by":"publisher","DOI":"10.1097\/ADM.0000000000000353"},{"key":"e_1_2_8_78_1","article-title":"QTc interval screening for cardiac risk in methadone treatment of opioid dependence","volume":"6","author":"Pani PP","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_8_79_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-122-9-199505010-00009"},{"key":"e_1_2_8_80_1","doi-asserted-by":"publisher","DOI":"10.3109\/00952990.2013.804525"},{"key":"e_1_2_8_81_1","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.166.12.1280"},{"key":"e_1_2_8_82_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2012.09.016"},{"key":"e_1_2_8_83_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2010.01.001"},{"key":"e_1_2_8_84_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.289.16.2120"},{"key":"e_1_2_8_85_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(02)01455-9"},{"key":"e_1_2_8_86_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpain.2014.01.494"},{"key":"e_1_2_8_87_1","doi-asserted-by":"publisher","DOI":"10.1592\/phco.2005.25.11.1523"},{"key":"e_1_2_8_88_1","doi-asserted-by":"publisher","DOI":"10.1592\/phco.23.6.802.32186"},{"issue":"5","key":"e_1_2_8_89_1","article-title":"Alpha\u2082\u2010adrenergic agonists for the management of opioid withdrawal","volume":"2016","author":"Gowing L","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_8_90_1","doi-asserted-by":"publisher","DOI":"10.1111\/ajad.12862"},{"key":"e_1_2_8_91_1","doi-asserted-by":"publisher","DOI":"10.3109\/00952990.2011.653426"},{"key":"e_1_2_8_92_1","article-title":"Hydroxyzine for generalised anxiety disorder","volume":"12","author":"Guaiana G","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"e_1_2_8_93_1","first-page":"S11","article-title":"Loperamide: a pharmacological review","volume":"7","author":"Baker DE","year":"2007","journal-title":"Rev Gastroenterol Disord"},{"key":"e_1_2_8_94_1","unstructured":"Providers' Clinical Support System for Medication Assisted Treatment. XR\u2010Naltrexone: A step\u2010by\u2010step guide.\u00a0Accessed May 24 2022.http:\/\/pcssnow.org\/wp-content\/uploads\/2017\/02\/Naltrexone_Step-by-Step_Virtual_Brochure-1.pdf"},{"key":"e_1_2_8_95_1","article-title":"Oral naltrexone maintenance treatment for opioid dependence","volume":"2","author":"Minozzi S","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_8_96_1","doi-asserted-by":"publisher","DOI":"10.1111\/jcpt.12196"},{"key":"e_1_2_8_97_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-1241.2008.01990.x"},{"key":"e_1_2_8_98_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-200969050-00006"},{"key":"e_1_2_8_99_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-144-2-200601170-00010"},{"key":"e_1_2_8_100_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2004.05.002"},{"key":"e_1_2_8_101_1","doi-asserted-by":"publisher","DOI":"10.1016\/0376-8716(80)90455-X"},{"key":"e_1_2_8_102_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0885-3924(00)00252-9"},{"key":"e_1_2_8_103_1","doi-asserted-by":"publisher","DOI":"10.1093\/pm\/pny019"},{"issue":"1","key":"e_1_2_8_104_1","first-page":"E1","article-title":"Buprenorphine formulations: clinical best practice strategies recommendations for perioperative management of patients undergoing surgical or interventional pain procedures","volume":"21","author":"Jonan AB","year":"2018","journal-title":"Pain Physician"},{"key":"e_1_2_8_105_1","doi-asserted-by":"publisher","DOI":"10.1093\/pm\/pny217"},{"key":"e_1_2_8_106_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12630-018-1255-3"},{"key":"e_1_2_8_107_1","doi-asserted-by":"publisher","DOI":"10.12788\/jhm.3265"},{"key":"e_1_2_8_108_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-020-06115-3"},{"key":"e_1_2_8_109_1","doi-asserted-by":"publisher","DOI":"10.1136\/rapm-2021-103007"},{"key":"e_1_2_8_110_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcna.2021.09.001"},{"key":"e_1_2_8_111_1","unstructured":"Society of Hospital Medicine. New Buprenorphine Practice Guidelines: FAQs.\u00a02022. Accessed May 24 2022.https:\/\/www.hospitalmedicine.org\/globalassets\/practice-management\/practice-management-pdf\/x-waiver-faq.pdf"},{"key":"e_1_2_8_112_1","unstructured":"Substance Abuse and Mental Health Services Administration. Buprenorphine waiver notification. Accessed May 24 2022.https:\/\/buprenorphine.samhsa.gov\/forms\/select-practitioner-type.php"},{"key":"e_1_2_8_113_1","unstructured":"American Society of Addiction Medicine. Buprenorphine mini\u2010course: Building on Federal Prescribing Guidance.\u00a0Accessed May 24 2022.https:\/\/elearning.asam.org\/products\/buprenorphine-mini-course-building-on-federal-prescribing-guidance#tab-product_tab_overview"},{"key":"e_1_2_8_114_1","unstructured":"Substance Abuse and Mental Health Services Administration. Find treatment.\u00a0Accessed May 24 2022.https:\/\/findtreatment.gov\/"},{"key":"e_1_2_8_115_1","unstructured":"Substance Abuse and Mental Health Services Administration. Buprenorphine practitioner locator. Accessed May 24 2022.https:\/\/www.samhsa.gov\/medication-assisted-treatment\/find-treatment\/treatment-practitioner-locator"},{"key":"e_1_2_8_116_1","unstructured":"ATLAS. Find high\u2010quality addiction treatment.\u00a02022. Accessed May 24 2022.https:\/\/www.treatmentatlas.org\/"},{"key":"e_1_2_8_117_1","unstructured":"Substance Abuse and Mental Health Services Administration. FAQs: Provison of methadone and buprenorphine for the treatment of opioid use disorder in the COVID\u201019 emergency. April 21 \u00a02022. Accessed May 24 2022.https:\/\/www.samhsa.gov\/sites\/default\/files\/faqs-for-oud-prescribing-and-dispensing.pdf"},{"key":"e_1_2_8_118_1","first-page":"1","article-title":"Telehealth utilization is associated with lower risk of discontinuation of buprenorphine: a retrospective cohort study of US veterans","volume":"37","author":"Vakkalanka JP","year":"2021","journal-title":"J Gen Intern Med"},{"key":"e_1_2_8_119_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2021.108543"},{"key":"e_1_2_8_120_1","doi-asserted-by":"crossref","unstructured":"GuillenAG ReddyM SaadatS ChakravarthyB.Utilization of telehealth solutions for patients with opioid use disorder using buprenorphine: a scoping review.Telemed J E Health. Published online October 29 2021.doi:10.1089\/tmj.2021.0308","DOI":"10.1089\/tmj.2021.0308"},{"key":"e_1_2_8_121_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2021.108283"},{"key":"e_1_2_8_122_1","doi-asserted-by":"publisher","DOI":"10.1111\/ajad.12161"},{"key":"e_1_2_8_123_1","unstructured":"Substance Abuse and Mental Health Services Administration. Behavioral health treatment services locator.\u00a0Accessed May 24 2022.https:\/\/findtreatment.samhsa.gov\/"},{"key":"e_1_2_8_124_1","unstructured":"SMART\u00a0Recovery. There's life beyond addiction.\u00a02022. Accessed May 24 2022.https:\/\/www.smartrecovery.org\/"},{"key":"e_1_2_8_125_1","unstructured":"Narcotics Anonymous. Find A Meeting.\u00a02012. Accessed May 24 2022.https:\/\/www.na.org\/meetingsearch\/"},{"key":"e_1_2_8_126_1","unstructured":"National Harm Reduction. Find Harm Reduction Resources Near You.\u00a0Accessed May 24 2022.https:\/\/harmreduction.org\/resource-center\/harm-reduction-near-you\/"},{"key":"e_1_2_8_127_1","unstructured":"Faces & Voices of Recovery. ARCO Members on the Map. Accessed May 24 2022.https:\/\/facesandvoicesofrecovery.org\/"},{"key":"e_1_2_8_128_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcna.2021.09.002"},{"key":"e_1_2_8_129_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12954-022-00594-9"},{"key":"e_1_2_8_130_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12954-022-00622-8"},{"key":"e_1_2_8_131_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2021.103324"},{"key":"e_1_2_8_132_1","doi-asserted-by":"publisher","DOI":"10.1590\/s1980-220x2018051803591"},{"key":"e_1_2_8_133_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12954-018-0258-2"},{"key":"e_1_2_8_134_1","doi-asserted-by":"publisher","DOI":"10.1097\/ADM.0000000000000693"},{"key":"e_1_2_8_135_1","unstructured":"The United States Attorney's Office. U.S. Attorney's Office Settles Disability Discrimination Allegations with Operator of Skilled Nursing Facilities.\u00a0December 29 \u00a02020. Accessed May 24 2022.https:\/\/www.justice.gov\/usao-ma\/pr\/us-attorney-s-office-settles-disability-discrimination-allegations-operator-skilled-0"},{"key":"e_1_2_8_136_1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm7006a4"},{"key":"e_1_2_8_137_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2019.6215"},{"issue":"23","key":"e_1_2_8_138_1","first-page":"631","article-title":"Opioid overdose prevention programs providing naloxone to laypersons\u2014United States, 2014","volume":"64","author":"Wheeler E","year":"2015","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"e_1_2_8_139_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.f174"},{"key":"e_1_2_8_140_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2017.05.001"},{"key":"e_1_2_8_141_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0955-3959(01)00080-9"},{"key":"e_1_2_8_142_1","doi-asserted-by":"publisher","DOI":"10.1080\/08897077.2016.1238431"},{"key":"e_1_2_8_143_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2015.10.013"},{"key":"e_1_2_8_144_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMsa064115"},{"key":"e_1_2_8_145_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-159-9-201311050-00005"},{"key":"e_1_2_8_146_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2011.05.001"},{"key":"e_1_2_8_147_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2021.0976"},{"key":"e_1_2_8_148_1","unstructured":"Institute of Medicine Committee on Federal Regulation of Methadone Treatment.\u00a0In:\u00a0Rettig RA Yarmolinsky A eds.Federal Regulation of Methadone Treatment. National Academies Press;\u00a01995.\u00a0\u00a0"},{"key":"e_1_2_8_149_1","doi-asserted-by":"publisher","DOI":"10.7326\/M21-3968"}],"container-title":["Journal of Hospital Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/jhm.12893","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/jhm.12893","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/shmpublications.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/jhm.12893","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T14:44:21Z","timestamp":1760625861000},"score":1,"resource":{"primary":{"URL":"https:\/\/shmpublications.onlinelibrary.wiley.com\/doi\/10.1002\/jhm.12893"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,26]]},"references-count":148,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["10.1002\/jhm.12893"],"URL":"https:\/\/doi.org\/10.1002\/jhm.12893","archive":["Portico"],"relation":{},"ISSN":["1553-5592","1553-5606"],"issn-type":[{"value":"1553-5592","type":"print"},{"value":"1553-5606","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,26]]},"assertion":[{"value":"2022-01-14","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-05-29","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-07-26","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}